Skip to content

Dynamic Scaffold Versus Lichtenstein Open Hernioplasty.

The DySLOH Study: Dynamic Scaffold Versus Lichtenstein Open Hernioplasty. A Comparative Outcome Assessment Between the Two Techniques.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05706662
Acronym
DYSLOH
Enrollment
188
Registered
2023-01-31
Start date
2018-01-01
Completion date
2022-12-31
Last updated
2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal Hernia

Keywords

inguinal hernia repair, ProFlor technique, lichtenstein hernia repair

Brief summary

Evaluating the outcomes of patients undergoing open anterior inguinal hernioplasty comparing two different techniques: Lichtenstein/plug and mesh and ProFlor. The outcomes of these two groups of patients, respectively the Lichtenstein inguinal hernia repair with static flat mesh and the defect obliteration with 3D dynamic scaffold Proflor, are compared in respect to defined variables along stages: intraoperative, early and long term postoperative.

Interventions

PROCEDUREinguinal hernia repair with mesh

inguinal hernia repair with mesh

Sponsors

University of Palermo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Eligible patients were individuals aged between 18 and 85 years old, competent to give consent, affected by clinically relevant primary inguinal hernia scheduled to undergo elective inguinal hernia repair and eligible for outpatient surgical procedure with local anesthesia.

Exclusion criteria

* Recurrent inguinal hernia * Incarcerated inguinal hernia * Hernia not in the inguinal area * Signs of obvious local or systemic infection * ASA score \> 4 * Presenting with unstable angina or NYHA class of IV * Pregnant * Active drug user * Immunosuppression, chemotherapy * Chronic renal insufficiency * Abdominal ascites * Infection in area of the surgical field * BMI \>35

Design outcomes

Primary

MeasureTime frameDescription
patients clinical outcome24 monthsVAS score
early postoperative complications30 days after surgerybleeding, hematoma and infections

Secondary

MeasureTime frameDescription
evaluation of quality of life during the postoperative period24 monthsCarolina Comfort Scale - CCS

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026